![The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study](https://www.jcancer.org/v12/p5644/jcav12p5644g003.jpg)
The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study
![Basic clinical background on small cell lung cancer (SCLC) (in the text... | Download Scientific Diagram Basic clinical background on small cell lung cancer (SCLC) (in the text... | Download Scientific Diagram](https://www.researchgate.net/publication/359405081/figure/fig1/AS:1147710069575686@1650646812678/Basic-clinical-background-on-small-cell-lung-cancer-SCLC-in-the-text-box-left-with_Q320.jpg)
Basic clinical background on small cell lung cancer (SCLC) (in the text... | Download Scientific Diagram
![Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730420300012-gr2.jpg)
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect
![JCM | Free Full-Text | Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer JCM | Free Full-Text | Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer](https://pub.mdpi-res.com/jcm/jcm-12-02355/article_deploy/html/images/jcm-12-02355-g001.png?1679058327)
JCM | Free Full-Text | Only EBUS-Guided Mediastinal Lymph Node Cryobiopsy Enabled Immunotherapy in a Patient with Non-Small Cell Lung Cancer
![Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730420300012-gr1.jpg)
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect
![Frontiers | Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma Frontiers | Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma](https://www.frontiersin.org/files/Articles/748557/fonc-12-748557-HTML/image_m/fonc-12-748557-g001.jpg)
Frontiers | Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma
![Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-28840-5/MediaObjects/41467_2022_28840_Fig1_HTML.png)
Clinical and genomic features of Chinese lung cancer patients with germline mutations | Nature Communications
![P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether](https://thorax.bmj.com/content/thoraxjnl/67/Suppl_2/A151.1/F1.large.jpg)
P199 Merseyside & Cheshire Cancer Network (MCCN) Audit: Survival Analysis of Lung Cancer Patients with a Performance Status of 3 (PS3) Based Upon the Reason For Their Poor Performance Status and Whether
![Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma](https://www.mdpi.com/cancers/cancers-14-02281/article_deploy/html/images/cancers-14-02281-g001.png)
Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma
![PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network](https://www.researchgate.net/publication/336972259/figure/fig3/AS:962802894262279@1606561506425/Kaplan-Meyer-curve-of-time-from-last-chemotherapy-cycle-to-date-of-progression-or-death_Q320.jpg)
PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network
![Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian | Cancer Cell International | Full Text Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-022-02588-w/MediaObjects/12935_2022_2588_Fig3_HTML.png)
Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian | Cancer Cell International | Full Text
![Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors - ScienceDirect Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500215001725-gr2.jpg)